Correlation between the Warburg effect and progression of triple-negative breast cancer

被引:14
|
作者
Liu, Shaojun [1 ]
Li, Yuxuan [1 ]
Yuan, Meng [1 ]
Song, Qing [1 ]
Liu, Min [1 ]
机构
[1] Nanjing Univ Chinese Med, Dept Oncol, Suzhou TCM Hosp, Suzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 12卷
基金
中国国家自然科学基金;
关键词
Warburg effect; glycolysis; metabolic plasticity; triple-negative breast cancer; basal-like breast cancer; METABOLIC PATHWAYS; CELL COMPETITION; DRUG-RESISTANCE; TUMOR DORMANCY; METASTASIS; MECHANISMS; INHIBITION; PROMOTES; CYCLE; ACTIVATION;
D O I
10.3389/fonc.2022.1060495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Triple-negative breast cancer (TNBC) is ineligible for hormonal therapy and Her-2-targeted therapy due to the negative expression of the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor-2. Although targeted therapy and immunotherapy have been shown to attenuate the aggressiveness of TNBC partially, few patients have benefited from them. The conventional treatment for TNBC remains chemotherapy. Chemoresistance, however, impedes therapeutic progress over time, and chemotherapy toxicity increases the burden of cancer on patients. Therefore, introducing more advantageous TNBC treatment options is a necessity. Metabolic reprogramming centered on glucose metabolism is considered a hallmark of tumors. It is described as tumor cells tend to convert glucose to lactate even under normoxic conditions, a phenomenon known as the Warburg effect. Similar to Darwinian evolution, its emergence is attributed to the selective pressures formed by the hypoxic microenvironment of pre-malignant lesions. Of note, the Warburg effect does not disappear with changes in the microenvironment after the formation of malignant tumor phenotypes. Instead, it forms a constitutive expression mediated by mutations or epigenetic modifications, providing a robust selective survival advantage for primary and metastatic lesions. Expanding evidence has demonstrated that the Warburg effect mediates multiple invasive behaviors in TNBC, including proliferation, metastasis, recurrence, immune escape, and multidrug resistance. Moreover, the Warburg effect-targeted therapy has been testified to be feasible in inhibiting TNBC progression. However, not all TNBCs are sensitive to glycolysis inhibitors because TNBC cells flexibly switch their metabolic patterns to cope with different survival pressures, namely metabolic plasticity. Between the Warburg effect-targeted medicines and the actual curative effect, metabolic plasticity creates a divide that must be continuously researched and bridged.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Chemoimmunotherapy for Triple-Negative Breast Cancer
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (24): : 2521 - 2521
  • [42] Targeting triple-negative breast cancer
    Kirkpatrick, Peter
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) : 21 - 21
  • [43] Pathogenesis of Triple-Negative Breast Cancer
    Derakhshan, Fatemeh
    Reis-Filho, Jorge S.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2022, 17 : 181 - 204
  • [44] Imaging of triple-negative breast cancer
    Dogan, B. E.
    Turnbull, L. W.
    ANNALS OF ONCOLOGY, 2012, 23 : 23 - 29
  • [45] Establishment of triple-negative breast cancer cells based on BMI: A novel model in the correlation between obesity and breast cancer
    Shveid Gerson, Daniela
    Gerson-Cwilich, Raquel
    Lara Torres, Cesar Octavio
    Chousleb de Kalach, Alberto
    Ventura Gallegos, Jose Luis
    Ernesto Badillo-Garcia, Luis
    Bargallo Rocha, Juan Enrique
    Maffuz-Aziz, Antonio
    Sanchez Forgach, Ernesto Roberto
    Castorena Roji, Gerardo
    Robles Vidal, Carlos D.
    Vargas-Castillo, Ariana
    Torres, Nimbe
    Tovar, Armando R.
    Contreras Jarquin, Mariela
    Gomez Osnaya, Jesus Tenahuatzin
    Zentella-Dehesa, Alejandro
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Immunotherapy in triple-negative breast cancer
    Katz, Heather
    Alsharedi, Mohamed
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [47] An overview of triple-negative breast cancer
    Pankaj Kumar
    Rupali Aggarwal
    Archives of Gynecology and Obstetrics, 2016, 293 : 247 - 269
  • [48] Triple-negative breast cancer in the elderly
    Shagisultanova, Elena
    Mayordomo, Jose
    Elias, Anthony D.
    BREAST JOURNAL, 2017, 23 (06): : 627 - 629
  • [49] Characteristics of triple-negative breast cancer
    Tim C. de Ruijter
    Jürgen Veeck
    Joep P. J. de Hoon
    Manon van Engeland
    Vivianne C. Tjan-Heijnen
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 183 - 192
  • [50] Male Triple-Negative Breast Cancer
    Qavi, Qasif
    Alkistawi, Firas
    Kumar, Shashi
    Ahmed, Rizwan
    Al-Zawi, Abdalla Saad Abdalla
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)